Medtronic Inc (USA) Hero Image

Medtronic

Medtronic, a global healthcare technology company specializing in medical devices and therapies, invested $2.74 billion in R&D and held 202 active patent families in 2023. Its technologies address over 70 health conditions, integrating AI, data analytics, and robotics into healthcare. Medtronic's innovation strategy includes an AI Center of Excellence, an Innovation Lab, and strategic partnerships. Medtronic LABS' SPICE, an open-source digital platform, uses machine learning to improve healthcare delivery in underserved communities.

Founded 1949
Visit Website

Overview

Featured Content

Medtronic AI Center of Excellence

A dedicated center focused on integrating artificial intelligence and machine learning into Medtronic's medical devices and therapies.

Research Areas

Medical DevicesCardiovascular TechnologyNeurosurgeryHealthcare ServicesTherapeutic InnovationsMedical TherapiesLess-invasive Surgical TechniquesAI and Machine Learning in HealthcareRobotic-Assisted SurgeryDiabetes ManagementStructural Heart TreatmentsExtracorporeal Membrane Oxygenation (ECMO)Spine Surgery

R&D 100 Awards

Total Awards: 2

Publications per Year

Data for 2024 is incomplete and represents only part of the year.

Patents per Year

Patent counts updated based on IFI Claims data combining Medtronic Inc, Medtronic Minimed Inc, and Medtronic Vascular Inc.

Location on Map

Related Content

What Medtronic learned on its long road to RDN approval

What Medtronic learned on its long road to RDN approval

Read More

Explore More Labs